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Abstract 
     Necrotizing enterocolitis (NEC) is a leading cause of mortality and morbidity in the neonatal intensive care 
unit, until now the etiology of NEC remains unclear, prevention and treatment strategies are often inadequate. 
The protective effect of L-arginine was examined in an experimental model of necrotizing entercolitis. The study 
was conducted on 46 male albino rats which were divided into three main groups:  Control group, L-arginine 
group, and the experimental group which has been divided into two sub-groups; Group A: received 
Lipopolysaccharides to induce NEC, Group B: injected by L-arginine prior to the disease was induced by 
endotoxin, asphyxia and cold stress. After the animals had been scarified, histological changes in the ilium were 
evaluated, gene expression of both iNOS and IL-12 were measured, and apoptosis also was detected by 
flowcytometry technique. The findings observed a significant increase in the expression of iNOS gene and IL-12 
gene and a noticeable decrease of the apoptosis index. In addition, administration of L-arginine attenuated body 
weight, body temperature, and the histological changes that was altered by LPS/asphyxia. As such, the study was 
able to demonstrate that L-arginine administration had significant protective effect against NEC, but further 
clinical studies are still required on preterm infant to confirm these results. 
Key words: Necrotizing enterocolitis, L-arginine, Interleukin-12, Inducible nitric oxide synthase, 
Lipopolysaccharides, Messenger Ribonucleic acid (mRNA) 
1. Introduction 
Necrotizing enterocolitis (NEC) is the most common and acute life-threatening medical and surgical emergency 
of the intestine encountered in preterm infants. It had many symptoms that could be severe and injurious to one 
or more organs resulting in pulmonary, renal and hepatic failure
 
(Mitidiero LF et al., 2014). For developing NEC, 
multifactorial and complex factors can cause its development. In addition, the diagnosis of NEC is based on 
clinical and radiologic findings which included several medications. Assessing gene-expression patterns could be 
by transcriptomics that has a future promise in determining biomarkers in necrotizing enterocolitis researches 
field. Therefore, the main objective of this study is to evaluate the effectiveness of L-arginine administration in 
necrotizing enterocolitis model in rats using quantification analysis of inducible nitric oxide synthase (iNOS) and 
interleukin-12 (IL-12) genes.  
 
2. Theoretical Background 
 NEC is an acute inflammatory disease that affects the neonatal intestine leading to intestinal necrosis, multi-
system organ impairment and septicemia (Lin and Stoll, 2006). It is affecting 5% to 10% of premature infants 
less than 36 weeks of gestation and weighing under 1,500 g, with an associated mortality rate of 10% to 50% 
(Chu et al., 2013). Kastenberg et al. (2013) added that about 50% of the affected baby would develop progressive 
intestinal necrosis requiring an urgent operation. It is not considered only as a most serious clinical problem 
which affects preterm infants, but also one of the most challenging to treat. 
The incidence of NEC has increased to7% in very-low-birth-weight infants. The overall mortality rate for infants 
with NEC ranging from 15-30% (Lee, 2011) but close to 100% in preterm infants who are suffering from the 
rapidly progressive disease. Accordingly, effective medications were evaluated including L-arginine which is a 
semi-essential cationic amino acid that is utilized as a sole substrate in the synthesis of Nitric Oxide (NO), 
through L-arginine oxidation, that catalyzed by the nitric oxide synthase enzyme (NOS). Nitric oxide acts as a 
neurotransmitter for enteric non-adrenergic non-cholinergic neurons and inadequacy of NO can alter intestinal 
motility; NO inhibits leucocytes actions and changes the inflammatory responses in the intestine.  
Ford H et al. (1997) elaborated that iNOS gene is detected in specimens of infants surgically resected for NEC. 
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On the other hand, Dvorak B et al. (2003) discussed that despite the presence of endothelial NO synthase (eNOS) 
in specimens from infants undergoing surgical resection for NEC and control patients with intestinal atresia, 
eNOS function was impaired, resulting in decreased NO production in arterioles from NEC specimens compared 
with controls. Accordingly, NO with the normal concentration in the gastrointestinal (GI) tract is very important 
since patients with mild NEC require GI rest to facilitate resolution of the intestinal inflammatory process (Akisu, 
2002). 
Moreover, Transcriptomics is a global way of assessing gene-expression patterns since it involves all mRNA 
molecules studies, or transcripts, and evaluation of the changes in the initiation of transcription, processing, and 
degradation of proteins. Polymerase chain reaction (PCR) technique, based on transcriptomics, holds promise in 
discovering biomarkers in the area of NEC research in the future. The question of enteral versus parenteral 
administration should be carefully considered where one potential advantage of enteral administration is that the 
arginine could have significant beneficial effects on the intestinal mucosa itself, increasing proliferation and 
differentiation due to the production of other amino acids and polyamines. Moreover, preventing a catabolism-
induced production of asymmetric dimethyl arginine (ADMA) by overall nutrition that may decrease NOS 
activity and NO production by need careful attention since its ratio can affect the intestinal microvasculature and 
potentially predisposing to NEC.  
3. Methodology 
3.1. Material  
 Animals: The present study was conducted in King AbdulAziz University (KAU) where the investigation 
was divided into two phases which are: Pilot study phase and Experimental study phase. In the pilot study, 
fourteen male albino rats weighing (30-50 gram) were used, and forty-six male albino rats weighing (30-50 
gram) were used throughout the experimental study. They were placed in plastic cages in animal house and 
subjected to standard settings and were given freely water at all times and standard laboratory chow and 
were exposed to a temperature from (20–25◦ C) and humidity of (50 ± 5%) on a 12 h light/dark cycle for one 
week acclimation before use.   
 Drugs: Firstly, L-arginine (Amargine® 100 mg/mL) bought from King AbdulAziz University Hospital 
which was given orally (261mg/kg/day) (1,5mmol/kg/day) (Douglas, 2004). Secondly, Sodium 
pentobarbital purchased from Sigma Aldrich Co. as a white powder dissolved in sterile water to a 
concentration of 50 mg/mL solution for the intraperitoneal injection in a dose of 40 mg/kg/day (Chan et al., 
2009). 
 Chemicals: The study used several chemicals which are: Lipopolysaccharides 10 mg (LPS) a powder 10 
mL of phosphate buffer saline to make the final concentration is (1 mg/mL); Ethyl ether; Formaldehyde; 
Liquid nitrogen; Phosphate buffered saline powder (PPS); TACS Annexin V-FITC Kit, for measurement of 
antiapoptic effect of L-arginine; Rat Interleukin 12 (IL-12/P70) ELISA Kit; RNeasy® Fibrous Tissue Mini 
Kit; RNase free DNase; High capacity cDNA Reverse Transcription Kit; Tagman® Gene expression Master 
Mix for both IL-12 and iNOS B genes. 
 Equipment: Rat rectal temperature probe (MLT1403, ADI Instruments); 45-50 °C incubators; 
Microcentrifuge ≥ 12,000 x g; ELISA Reader of measuring absorbance at 530-532 nm; 7500 Fast  Real-
Time PCR; Beckman Coulter flow cytometry.  
 
3.2. Methods 
3.2.1. Pilot Study: 
This study conducted a pilot to determine the appropriate dose of LPS to design an adequate experimental model 
for the study of necrotizing enterocolitis on full-term rats. Firstly, the study prepared the LPS 
(Lipopolysaccharides) that was supplied as lyophilized, γ-irradiated powders for reconstitution; 10 mL sterile 
balanced salt solution (BSS) which was added to the vial (10 mg) and swirled to make the final concentration is 
(1 mg/mL). Secondly, it prepared the L-arginine (Arginine solution) with (100 mg/mL) bottle that was kept out 
of light and at room temperature.  
 Pilot study design 
Fourteen male albino rats weighing (30-50 gm) were used throughout the study; they were divided into three 
groups. Group I contains two rats were injected with BSS (I.P.) as a control group. Group II contain 4 rats were 
injected with LPS 5 mg/kg/day (I.P.) for 2 days (Zhou W et al., 2011 and Lu H et al., 2006) and exposed to a 45 
seconds of asphyxia (in carbon dioxide hypoxic chamber) followed by cold stress (4°C for 10 min). Group III: 
contain 4 rats were injected with LPS 4 mg/kg/day (I.P.) for 2 days then they were exposed to a brief episode of 
asphyxia (45 seconds in carbon dioxide hypoxic chamber) followed by cold stress (4°C for 10 min) (Dvorak B et 
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al., 2003). Group IV: contain 4 rats were injected with LPS 2 mg/kg/day (I.P.) for 2 days (Feng J et al., 2006) 
then they were exposed to a brief episode of asphyxia (45 seconds in carbon dioxide hypoxic chamber) followed 
by cold stress (4°C for 10 min) (Dvorak B et al., 2003). Also, the previous procedures were performed twice 
daily (at 07:00 a.m. and 19:00 p.m.) for two consecutive days which were according to the study of Dvorak B et 
al. (2003). NEC evaluation: small intestine was visually evaluated after the animals had been sacrificed for 
typical signs of NEC (discoloration of the intestine, intestinal hemorrhage, ileal distention, and ileal stenosis). 
Ileal and jejunal tissues were collected and stained with hematoxylin and eosin for histologic evaluation 
according to Zhou W et al. (2011) 
3.2.2. Experimental induction of NEC: 
NEC was induced by intraperitoneal injection of LPS (2 mg/kg) (Feng J et al., 2006) to a full term neonatal rats 
then they were exposed to a brief episode of asphyxia (10 minutes in 10% carbon dioxide hypoxic chamber) 
followed by cold stress (4°C for 10 min) (Wei et al., 2007 & Zhou et al., 2011). 
 Experimental design: 
Forty-six rats were divided into 3 groups: Control (10 rats) which received BSS orally only for 10 days; second 
group: L-arginine only (12 rats) that received orally (261mg/kg/day) for 10 days; the third group which was 
subdivided into 2 subgroups (12 rats each). The first subgroup III a (LPS/asphyxia-induced rats) which received 
BSS orally for ten days before they were injected with intraperitoneal LPS (2 mg/kg/day once daily for two 
days). The second subgroup III b (LPS/asphyxia + L-arginine): (12 rats) were received L-arginine orally 
(261mg/kg/day) for ten days before they were injected with intraperitoneal LPS (2 mg/kg/day once daily for two 
days). Both sub-groups were exposed to a brief episode of asphyxia (45 seconds in carbon dioxide hypoxic 
chamber) followed by cold stress (4°C for 10 min), on the 11th and 12th day. This procedure was performed twice 
daily (at 7:00 a.m. and 19:00 p.m.) for two consecutive days. 
After the animals had been sacrificed (on the 48th hours after the last dose of LPS), the small intestine (ileal 
tissue) was immediately dissected then cut into many parts. One part (3 cm) immersed immediately in 10% 
neutral buffered formalin for light microscopy. It was stained with hematoxylin and eosin (H & A), Alcian blue 
and periodic acid chief (PAS) stains to study histopathological changes induced by necrotizing enterocolitis and 
the role of L- arginine as a protective agent. Another Fresh parts of intestine were sectioned into segments of 30 
mg of each and were placed in liquid nitrogen until use for detecting iNOS and IL-12 gene levels. Parts of 
intestine were snap-frozen in phosphate buffer saline for enterocyte apoptosis and interleukin 12 measurements. 
The rest of intestinal tissue frozen at - 80°C for further biochemical analysis. Moreover, the study measured the 
animal body weight, temperature, and histological features.  
 Experimental procedure:  
 The Sample was frozen immediately in liquid nitrogen and then ground to a fine powder under liquid nitrogen 
using mortar and pestle. The powder was transferred into polypropylene tube (RNase-free, liquid-nitrogen–
cooled) Liquid nitrogen allowed evaporate, Lysis buffered was added, and homogenization was continued as 
quickly as possible using a QIAshredder spin column. The study prepared TaqMan Gene Expression Assay, 
TaqMan Gene Expression Master Mix, cDNA Template, and RNase-free water. Furthermore, the protocol of 
gene expression was started with allowing the component to thaw on ice, completely resuspend by gently 
vortexing, and then briefly centrifuge. For each sample (to be run in Triplicate), pipet the following into a 
nuclease-free 1.5-mL microcentrifuge tube: 
PCR Reaction Mix Component Volume per 20-μL Reaction 
Single reaction Three replicates # 
1 20 x TaqMan Gene Expression Assay 1.0 4.0 
2 2 x TaqMan Gene Expression Master Mix 10.0 40.0 
3 cDNA Template (1 to 100 ng) - 
4 RNase-free water Up to 20 μL Up to 80 μL 
 
The study capped the tube and invert it several times to mix the reaction components, the centrifuge the tube 
briefly to transfer 20 μL of PCR reaction mix into each well 96-well reaction plate. Also, it sealed the plate with 
the appropriate cover and centrifuged the plate briefly. After that, the study created a plate document/experiment 
for the run. The plate was loaded into the instrument. 
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3.3. Data analysis 
The data were analyzed, and amplification plots were generated using the software program, 7500 fast real-time 
PCR. The comparative CT method used (2-ΔΔCT) for calculating the relative quantification of the target gene was 
used as follows ΔΔCT = (CT of target gene – CT of ACTB) for χ – (CT of target gene – CT, ACTB) for y, where 
χ = treated sample and y = control sample. After validation of the method, results for each sample were 
expressed in N-fold changes in χ target gene copies, normalized to ACTB relative to the copy number of the 
target gene in control, according to the following equation: the amount of target = 2-ΔΔCt. All data are presented 
as means ±SDV. Statistical analysis was performed using SPSS. P ≤ 0.05 was considered significant. 
Furthermore, all data were statistically processed with the SPSS program, version 21; both descriptive statistics 
and analytical statistics were done. Data were presented as means ± standard deviations. Comparison among 
different groups was carried out by non-parametric tests. The difference was considered statistically significant 
when P <0.05 
4. Results  
4.1. Pilot study result 
      Three rats were injected with (LPS 5 mg/kg) and drop out within 12 hours were the last rat which died after 
18 hours of the first LPS dose. Two rats were injected with (LPS 4 mg/kg) which were died after 24 hours. While 
all rats injected with (LPS 2 mg/kg) were survived for 48 hours from the last dose of endotoxin, and only one 
died after 48 hours. All rats developed diarrhea and exhibited abdominal distention after administration of LPS 
injection, and their appetite was lost. Locomotors activity of rats injected with the highest dose decreased after 2 
hours from the first dose of LPS, unlike other rats who have decreased their activity obviously after 24 hours. 
Visually, it was observed that there were intestinal hemorrhage and ileal distention in the small intestine of 
remaining rats that were injected with LPS 2 mg/kg/day. 
     Histologically, a Photomicrograph showing the changes in the small intestine in response to LPS 
administration (2mg/kg/day) in LPS/asphyxia induced necrotizing enterocolitis (figure 4.1b) in comparative with 
the control group (figure 4.1a). Intestinal tissue in which severe coagulative necrosis was given a score of 3. 
 
Figure 4.1: Photomicrograph of small intestine changes 
 
4.2. Effect of L-arginine administration on body weight of LPS/asphyxia induced enterocolitis in rats 
      The result from table (4.1) and table (4.2) showed that the administration of L-arginine for 10 days before 
LPS/asphyxia improved the body weight by 23.7% compared to control before the LPS/asphyxia, however, 
LPS/asphyxia reduced the body weight from (59.01±10.05) before LPS/ asphyxia to (53.19±9.85) after 
LPS/asphyxia. After 48 hours of LPS-asphyxia induction, the body weight in LPS/asphyxia+ L-arginine group 
was decreased by 2.3% (average) compared to before LPS/asphyxia. However, in LPS group, the body weight 
was decreased by 10.9 % compared to before LPS/asphyxia. 
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Table (4.1): Effect of L-arginine on body weight in LPS/asphyxia induced enterocolitis in rats. 
Rats weight (gm) 
Control 
(n=10) 
Mean ± STD 
L-arginine 
(n=12) 
Mean ± STD 
LPS/asphyxia 
(n=12) 
Mean ± STD 
LPS/asphyxia + 
L-arginine (n=12) 
Mean ± STD 
Day (1) 40.63 ± 4.74 36.80  ± 2.49 38.85 ± 5.73 40.07 ± 4.38 
Day (2) 42.18 ± 4.60 39.92±2.52 40.74 ± 6.21 42.14 ± 4.37 
Day (3) 43.90 ± 4.81 43.93 ± 2.89 42.86 ± 6.96 44.92 ± 4.72 
Day (4) 45.85 ± 4.89 48.80 ± 3.14 44.97 ± 7.42 48.62 ± 5.13 
Day (5) 48.22 ± 5.24 51.55 ± 3.45 47.52 ± 8.14 52.59 ± 5.17 
Day (6) 50.41 ± 5.84 55.29 ± 2.89 50.16 ± 8.95 56.62 ± 4.89 
Day (7) 52.78 ± 6.35 58.77 ± 2.82 52.49 ± 9.70 60.28 ± 5.16 
Day (8) 55.13 ± 6.51 63.08 ± 3.02 54.61 ±10.20 63.94 ± 5.08 
Day (9) 56.95 ± 6.83 67.50 ± 3.08 56.43 ± 10.43 68.11 ± 4.88 
Day (10) 59.14 ± 6.97 71.67 ± 3.05 58.32 ± 10.41 72.43 ± 5.50 
Day (11) Before LPS 61.84 ± 6.69 75.86 ± 3.93 59.01 ± 10.05 76.50 ± 5.49 
Day (13) Before sacrifice 65.81 ± 7.57  84.37 ± 4.41 53.19 ± 9.85  74.73 ± 5.57  
 
Table (4.2): Multiple Comparisons of body temperature among all experimental groups 
Groups Contrast Averaged Variable 
The change of rats weights over time 
L-arginine vs. Control Mean Difference 16.288 
Std. Error 2.927 
P 0.0001** 
LPS/asphyxia vs. Control Mean Difference -7.725 
Std. Error 3.057 
Sig. 0.016* 
LPS/asphyxia + L-arginine vs. Control Mean Difference 11.788 
Std. Error 2.927 
P 0.0001** 
L-arginine vs. LPS/asphyxia + L-arginine Mean Difference 4.499 
Std. Error 2.790 
P .115 
LPS/asphyxia vs. LPS/asphyxia + L-arginine Mean Difference -19.513 
Std. Error 2.927 
P 0.0001** 
* The Mean difference is Significant at the 0.05 level 
** The Mean difference is Significant at the 0.01 level 
In the present study, An ANOVA with repeated measures statistical analysis was applied to compare the mean 
differences between the four groups that have been split on two within subjects’ factors (The weight of rats on 
day 11 before LPS, The weight of rats on day 13 before sacrifice). In the table (4.2), the average change of rats' 
weights was statistically high which is significantly greater with (P<0.0001) in the L-arginine group and the 
LPS/asphyxia + L-arginine group comparing to the Control group. On the other hand, it was lesser with 
(P=0.016), in LPS/asphyxia group comparing to the Control group, and with (P<0.0001) in LPS/asphyxia + L-
arginine group comparing to the L-arginine group.  
 
4.3. Effect of L-arginine administration on body temperature of LPS/asphyxia induced enterocolitis in 
rats 
Administration of LPS together with asphyxia increased the body temperature significantly from (38.80± 0.63 to 
41.25±0.1oC); however, administration of L-arginine significantly lowered the body temperature nearly to the 
normal levels (41.25±0.1 oC in the LPS group to 39.37±0.5 oC in the L-arginine treated group) (Table 4.3). 
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Table (4.3): Effect of L-arginine administration on body temperature in LPS/asphyxia induced enterocolitis 
Groups Before LPS - day 11 
Mean± STD (degrees centigrade) 
After LPS - day 13 
Mean± STD (degrees centigrade) 
Control (n=10) 38.40 ± 0.40 38.50 ± 0.65** 
LPS/asphyxia (n=12) 38.80 ± 0.63 41.25 ± 0.1*  
LPS/asphyxia+ L- 
arginine (n=12) 
38.75 ± 0.49 39.37 ± 0.5**  
*Significant change compared with the corresponding control group values                  
** Significant change compared with the corresponding LPS group values 
Significance was considered at P<0.05 
 
4.4. Effect of L-arginine administration on iNOS mRNA gene expression of LPS/ asphyxia induced 
enterocolitis in rats 
      LSD pair comparison table (4.4) and showed a significant increase in the expression of iNOS gene produced 
by oral administration of L-arginine (261 mg/kg/day) compared with control (P < 0.001) with mean± STD of and 
mean % change of 121.95 %. Also, the expression of iNOS gene in LPS/asphyxia group was statistically high 
significantly (5.812 ± 2.56) compared with Control group by 481.1%, p<0.0001 also it was statistically high 
significantly greater than L-arginine group (1.910 ± 0.460), p=0.001 and protected group (2.220 ± 0.7633), 
p=0.002. RT-PCR of ACTB mRNA was used as a housekeeping control. As such, highly significant differences 
statistical results were found between the groups of iNOS gene as determined by one-way ANOVA (F (3, 13) = 
10.583, p =0 .001).  
 
Table (4.4): Effect of daily oral administration of arginine for ten days on the expression of (iNOS) gene in 
experimental albino rats 
(I) Group Mean± STD (J) Group Mean 
Difference 
 (I-J) 
Sig 95% Confidence 
Interval 
Lower 
Bound 
Lower 
Bound 
 
Control 
 
1.00000 ±  E-9 
 
 
LPS/asphyxia -4.81211* 0.000 -6.8112- -2.81298- 
L-arginine -.90607 .321 -2.8026- 0.990466 
LPS/asphyxia
+ L-arginine 
-1.21954 0.210 -3.2186- 0.779587 
LPS/ 
asphyxia 
5.8121 ± 2.560 
Control 4.81211
*
 0.000 2.81298 6.811251 
L-arginine 3.90604
*
 0.001 2.00949 5.802584 
LPS/asphyxia
+ L-arginine 
3.59257
*
 0.002 1.59343 5.591705 
L-arginine 1.906 ± .4600 
Control .90607 0.321 -.99046- 2.802622 
LPS/asphyxia -3.90604* 0.001 -5.8025- -2.00949- 
LPS/asphyxia
+ L-arginine 
-.313468 0.727 -2.2100- 1.583076 
LPS/ 
asphyxia+ 
L-arginine 
2.219 ± .7633 
Control 1.21954 0.210 -.77958- 3.218679 
LPS/asphyxia -3.5925* 0.002 -5.5917- -1.59343- 
L-arginine .31346 0.727 -1.5830- 2.210012 
 
* The mean difference is significant at the 0.05 level 
 
4.5. Effect of administration of L-arginine for ten days as a protective agent on the expression of IL-
12 in experimental albino rats 
LSD pair comparison table (4.5) represented a significant increase by 113 % in the expression of IL-12 gene 
produced by oral administration of L-arginine compared with control (P < 0.001). In addition, the expression of 
IL-12 gene in LPS/asphyxia group was statistically high significantly (3.246±0.948) compared with the control 
group by 224.6%, p<0.0001. As such, LPS/asphyxia has high significant statistically results which is greater 
than L-arginine group (1.442±0.322), P <0.001 and protected group (2.130±0.690), p<0.015. 
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Table (4.5): Effect of daily oral administration of L-arginine for ten days on the expression of (IL-12) gene in 
experimental albino rats. 
 
(I) Group Mean± 
STD 
(J) Group Mean 
Difference 
 (I-J) 
Sig 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
 
Control 
 
1.00000 ±  
E-9 
 
 
LPS/asphyxia -2.246074-* .000 -3.05773- -1.434418- 
L-arginine -.4417673- .264 -1.25342- .3698887 
LPS/asphyxia+ 
L-arginine 
-1.130386-* .013 -1.99127- -.2694949- 
LPS/ 
asphyxia 
3.246 ± 
.94789 
Control 2.2460743
*
 .000 1.434418 3.0577305 
L-arginine 1.8043069
*
 .000 .9926508 2.6159631 
LPS/asphyxia
+ L-arginine 
1.1156880
*
 .015 .2547967 1.9765794 
L-arginine 
1.4417 ±. 
3220 
Control .441767380 .264 -.369888- 1.2534235 
LPS/asphyxia -1.804306-* .000 -2.61596- -.9926508- 
LPS/asphyxia+ 
L-arginine 
-.68861889- .109 -1.54951- .17227248 
LPS/ 
asphyxia+ 
L-arginine 
2.130 ± 
.69015 
Control 1.1303862* .013 .2694949 1.9912776 
LPS/asphyxia -1.115688-
*
 .015 -1.97657- -.254796- 
L-arginine .68861889 .109 -.172272- 1.5495102 
* The mean difference is significant at the 0.05 level 
 
4.6. Effect of L-arginine administration on apoptosis index of LPS/asphyxia induced enterocolitis in 
rats 
Data in the table (4.6) elaborated that the apoptosis mean high significantly less in L-arginine group (0.15 ± 0.17) 
compared to LPS/asphyxia + L-arginine group (4.16 ± 1.8) (P<0.001). Furthermore, there was no statistically 
significant difference between the means of late apoptosis based on the different groups. Necrotic cells means 
were statistically highly significant difference between the LPS/asphyxia group (9.17 ± 14.95) and LPS/asphyxia 
+ L-arginine group (0.15 ± 0.24) (P=0.009). As such, the highest mean of early apoptosis was for the 
LPS/asphyxia + L-arginine = 4.16, and the lowest mean was for L-arginine = 0.15. by LSD test.  
Table (4.6): Effect of L-arginine on apoptosis index in LPS/asphyxia induced enterocolitis in rats. 
Degree of 
apoptosis 
Parameter Control L-arginine LPS/asphyxia LPS/asphyxia + L-arginine 
(n=10) (n=12) (n=12) (n=12) 
Early 
apoptosis 
 
Mean ± STD 3.76 ± 4.71 0.15 ± 0.17 2.22 ± 2.41 4.16 ± 1.80 
min-max 0.03 -14.53 0.01 - 0.58 0.04 - 5.94 1.30 - 6.93 
Significance  *p=0.003 *p=0.280; 
**p=0.078 
*p=0.725; **p=0.001; ***p=0.099 
Late 
apoptosis 
 
Mean ± STD 0.52 ± 0.99 0.15 ± 0.34 0.37 ± 0.83 0.03 ± 0.03 
min-max 0.00 -3.15 0.00 -1.2 0.00 -2.59 0.00 -0.12 
Significance  *p=0.183 *p=0.606; 
**p=0.422 
*p=0.085; **p=0.667; ***p=0.228 
Necrosis 
 
Mean ± STD 2.73 ± 4.58 2.16 ± 3.80 9.17 ± 14.95 0.15 ± 0.24 
min-max 0.00 - 13.98 0.00 - 9.35 0.00 - 38.19 0.00 - 0.78 
Significance  
 
*p=0.864 *p=0.068; 
**p=0.039 
*p=0.437; **p=0.524; ***p=0.009 
*p: significance level for Control; **p: significance level for L-arginine; ***p: significance level for 
LPS/asphyxia. 
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4.7. Effect of L-arginine administration on IL-12 level using ELISA of LPS/asphyxia induced 
enterocolitis in rats 
Multiple comparison table (4.7) showed a significant increase of IL-12 level in LPS/asphyxia group (1048 ± 
202.09) greater than Control group (353.70 ± 167.28), p<0.0001 also it was statistically high significantly 
greater than L-arginine group (327.37 ± 185.88), p<0.0001 and LPS/asphyxia + L-arginine group (613.30 ± 
253.78), p<0.0001. 
Moreover, the IL-12 level of the protected group with L-arginine was relatively decreased by 41.5% than 
LPS/asphyxia group. Otherwise, there is a significant increase in LPS/asphyxia + L-arginine group mean 
(613.30±253.78) greater than Control group (353.70±167.28), p=0.007. Also, it is statistically high significantly 
greater than L-arginine group (327.37±185.88), p=0.003. 
 
Table (4.7): Effect of L-arginine on IL-12 level in experimentally rats using ELISA method 
(I) Group Mean± SD (J) Group Mean 
Difference 
 (I-J) 
Sig 95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
 
Control 353.701 ± 
167.283 
LPS/asphyxia -694.898788-* .000 -878.93- -510.866- 
L-arginine 26.328727 .761 -148.25- 200.916 
LPS/asphyxia
+L-arginine 
-259.596455-* .007 -443.62- -75.564- 
LPS/ 
asphyxia 
1048.60 ±  202.09 
Control 694.898788
*
 .000 510.866 878.930 
L-arginine 721.227515
*
 .000 537.195 905.2595 
LPS/asphyxia
+L-arginine 
435.302333
*
 .000 242.287 628.3167 
L-arginine 327.372 ±  185.87 
Control -26.328727- .761 -200.91- 148.259 
LPS/asphyxia -721.227515-* .000 -905.25- -537.195- 
LPS/asphyxia
+L-arginine 
-285.925182-
*
 .003 -469.95- -101.893- 
LPS/ 
Asphyxia + 
L-arginine 
613.298 ±  253.77 
Control 259.596455
*
 .007 75.5644 443.628 
LPS/asphyxia -435.302333-
*
 .000 -628.31- -242.287- 
L-arginine 285.925182
*
 .003 101.893 469.957 
* The mean difference is significant at the 0.05 level 
There is a highly significant difference between the groups of study F=26.477 and p<0.0001 
 
 
4.8. Histological results 
 Histological feature of rat ileum part in control group 
Sections of control rat ileum at the region of Payer's patch (figure 4.2) showed: 
o Intact elongated villi (black arrows) which were absent over lymphoid aggregation (star). 
o Villi have a normal connective central core and simple (black star) columnar covering epithelium with 
goblet cell (dotted arrows).  
o  The intestinal showed similar lining with few Panthers ill-defined cells at their bases. 
o The covering epithelium cover the patch is of cubical type (arrows). Germinal center was ill-defined (star) 
(H&E stain) 
Moreover, Sections from control rat ileum stained by (PAS) for neutral muco-polysaccharides (figure 4.3) 
showed positive staining of goblet cells (arrows) (PAS reaction) , while sections from control rat ileum stained 
by alcian blue stain for acidic muco-polysaccharides (figure 4.4) showed positive staining of goblet cells 
(arrows). 
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Figure (4.2): Photomicrograph of ileal sections from control group in experimentally rats using hematoxylin and 
eosin stain 
 
 
Figure (4.3): Photomicrograph of ileal sections from control group in 
experimentally rats using periodic acid chief stain 
 
 
Figure (4.4) Photomicrograph of ileal sections from control group in 
experimentally rats using alcian blue stain 
 Histological feature of rat ileum part in L-arginine group 
Sections of rat ilium after administration of L-arginine showed normal villi and payer's patches (star) (figure 4.5). 
Villi showed intact columnar and goblet cells (arrows). Payer's patches showed normal center (star). H & E 
stains for neutral and acid muco-polysaccharides showed normal goblet cells (arrows) 
 
 Histological feature of rat ileum part in LPS/asphyxia group 
Sections from rat ileum of LPS/asphyxia group showed: a. Marked necrosis of villi (arrows) and hypertrophy of 
muscle layer (star). b. Increase the size of the lymphoid follicle and its germinal center (figure 4.6). On the other 
hand, sections from the ileum of LPS group showed a & b: marked degeneration (necrosis) of mucosal lining and 
glands (white arrows) also muscles (black stars); (figure 4.7), showed hydropic degeneration. C & d: increase 
size of germinal centers of lymphoid follicles (dotted circle).  
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Figure (4.5) Photomicrograph of ileal sections from L-arginine group in experimentally rats 
 
 
Figure (4.6) Photomicrograph of ileal sections from LPS/asphyxia group in experimentally rats using 
hematoxylin and eosin stain 
 
 
Figure (4.7) Photomicrograph of ileal sections from LPS/asphyxia group in 
experimentally rats with marked necrosis using H & E stain 
 
 Histological feature of rat ileum part LPS/asphyxia + L-arginine group 
A Photomicrograph was showed the changes in the small intestine in response to L-arginine administration in 
LPS/asphyxia induced enterocolitis in rats. Sections from rat ileum mucosa of LPS/asphyxia + L –arginine 
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showed:  a. Intact villi with active goblet cells (arrows) slight inflammatory cells in villus core (star).  b and c: 
Follicle of payer patch with decrease germinal center (star) and normal intact overlying villi (black arrows) and 
crypts thick (white arrows). Follicle showed vacuolated cells (white arrows) (figure 4.8). 
 
Figure (4.8) Photomicrograph of ileal sections from LPS/asphyxia + L-arginine group in experimentally rats 
using H & E stain 
 
5. Discussion 
The overall goal of the present study was to validate a claim that the administration of orally L-arginine for 
preterm infants has a protective effect against NEC in rat model. In the beginning of this study it was compared 
different doses of LPS injection to induce NEC and then disease induction was validated by histopathology. 
Results showed that both doses (5 mg/kg/day and 4 mg/kg/day) of LPS injection after 24 hours are lethal and 
impracticable, in contrast with the collected data of the present study is the data of Zhou Wet al, (2011), who 
used a lethal dose of (LPS: 5 mg/kg) to induce intestinal injury. The mortality rate of NEC in groups 2 & 3 was 
75% and 50%, respectively. There was no morbidity and mortality in control group. Compared with control 
group injury to the intestine was severe in the LPS group with (2 mg/kg/day) dose. Based on the histological 
result, it showed that the optimal dose of LPS to induce NEC in term rats is (2 mg/kg/day) in addition to 
asphyxia and cold stress. In consistent with this study, the data of Feng et al., (2006). 
Moreover, the findings found that rats with enterocolitis produced by LPS/asphyxia showed reduced body 
weight by 10.9 % compared to before LPS/asphyxia, together had elevated body temperature significantly 
comparing to the control group. Administration of L-arginine as a protective agent before induction of 
necrotizing enterocolitis attenuated the body weight and body temperature to nearly normal value. In line with 
the current study was the data of Yao et al., (2008) that emphasized on the L-arginine supplementation ability to 
increase growth of neonatal pigs and promote weight gain which oppose the study of Osowska S et al. (2004) 
and Sukhotnik et al. (2005) who emphasized the non-significant alteration in final body weight of L-arginine rats. 
In addition, contrary to the related literature that indicated the NO possess a harmful role as an inflammatory 
mediator, the present study highlighted that NO production such as L-arginine may be beneficial in the 
prevention of NEC. 
In the present study, histopathological examination of LPS/asphyxia group revealed focal destruction of villi. 
The intestinal crypts looked disorganized with numerous unstained degenerated cells. As regards to the effect of 
L-arginine administration, the results obtained demonstrated that L-arginine produced significantly decreased of 
the histopathological damage in LPS/asphyxia induced NEC. The present results could be explained by L-
arginine provides NO that is known to have a protective role in the intestinal mucosa, as it prevents 
vasoconstriction by regulating of vascular perfusion and subsequently prevents the ischemia-induced damaging 
effects of mucosa (Fotiadis et al., 2004). 
 
6. Summary and Conclusion  
In conclusion, this small experimentally study has shown that L-arginine afforded significant protective 
effect against NEC. L-arginine may not prevent NEC completely but its use from the first days of life for a 
preterm infant may delay the NEC progression and alleviate the severity of this deadly disease. Moreover, 
according to the results obtained in the present study, the rationale for using L-arginine as a protective agent for 
NEC was supported by; antiapoptotic effect of L-arginine (a NO synthase substrate) which was significantly 
decreased of apoptosis index and necrosis in protective group, L-arginine caused interruption of the 
inflammatory cascade and significant upregulation of both iNOS and IL-12 mRNA gene expression compared to 
control and LPS/asphyxia group. Also, significantly attenuated body weight & body temperature, histological 
changes, and intestinal injury which were altered by LPS/asphyxia. Moreover, it is recommended that L-arginine 
could be provided as a protective agent for the high-risk neonatal group. Further studies are highly required to 
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shed the lighter on the possible protective mechanism of L-arginine in NEC. Further evidence is required to 
confirm these results in large, prospective, randomized, placebo-controlled studies. Also, to focus on the possible 
adverse effects that may arise due to L-arginine administration in preterm infants.  
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